A significant shift in the country's drug policy has happened, as the regulators permit the use of psilocybin mushrooms for therapeutic purposes. Previously, these substances were severely restricted, but a mounting body of evidence suggests they potentially offer relief for mental health illnesses like depression. The new policy represents a major